Amputation Risk Leads To Boxed Warning On Diabetes Drugs
The U.S. Food and Drug Administration on Tuesday said it has confirmed that Janssen Pharmaceuticals' diabetes medications Invokana and Invokamet can increase the risk of patients needing to have their legs...To view the full article, register now.
Already a subscriber? Click here to view full article